We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Global Automated Immunoassay Analyzer Market Driven by Increase in Applications

By LabMedica International staff writers
Posted on 18 Apr 2019
The global automated immunoassay analyzer market is expected to achieve significant growth over the coming years, driven by innovations in the existing products and increased clinical applications of these systems. These are the latest findings of Radiant Insights (San Francisco, CA, USA), a market research and consulting company.

Other factors such as the growing inclination towards lab automation, increase in the number of infectious diseases, rise in the use of these systems due to their extensive test menu at affordable prices, and increased use of immunoassay tests for cancer will further contribute to the growth of the global automated immunoassay analyzer market. However, the lack of skilled specialists due to increasing healthcare needs globally and unavailability of healthcare professionals in the developing economies is hampering the growth of the automated immunoassay analyzer market.

The major players in the automated immunoassay analyzer market are increasingly focusing on new product launches along with technical enhancements and expansion of their product portfolio in order to meet the requirements for assay menus, test volumes, budgets, and automation levels among various laboratories. Moreover, the increasing number of biomedical tests for measuring proteins and growing awareness about analyzers in the developing countries are also fueling the growth of the automated immunoassay analyzer market.

Related Links:
Radiant Insights


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Immunofluorescence Analyzer
IFA System
New
Hematology Consumables
Bioblood Devices

Latest Industry News

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
18 Apr 2019  |   Industry

FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy
18 Apr 2019  |   Industry

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
18 Apr 2019  |   Industry



ADLM